CDC advisory panel in favor of Pfizer vaccine booster for ages 12 to 15

A panel of outside experts advising the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday voted to recommend booster shots of Pfizer Inc and BioNTech SE's COVID-19 vaccine be made available to 12- to 15-year-olds. The CDC's Advisory Committee on Immunization Practices (ACIP) voted 13 to 1 to recommend that the U.S. health agency support booster shots for those aged 12 to 15 at least five months after their second dose. The panel also said the CDC should strengthen its recommendation for boosters ages 16 and 17. The agency had previously made the shots available to those teenagers, but had stopped short of suggesting that all of them should receive the additional jab.